Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Transaction in Own Shares

2 Mar 2020 16:00

RNS Number : 7300E
Coca-Cola European Partners plc
02 March 2020
 

2 March 2020

 

COCA-COLA EUROPEAN PARTNERS PLC

(the "Company")

 

Transactions in Own Shares

 

The Company announces that it has purchased the following number of its ordinary shares of EUR 0.01 each through Credit Suisse Securities (USA) LLC. The purchased shares have all been cancelled.

 

These share purchases form part of the Company's existing buyback programme, as announced on 13 February 2020, in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 29 May 2019 (the "Buyback Programme"). The Company will make further announcements in due course following the completion of any further purchases pursuant to the Buyback Programme.

 

USX purchases

 

Daily aggregated information by trading venue

 

Date of purchase

Aggregate number of ordinary shares of EUR 0.01 each purchased

Highest price paid per share (USX)

Lowest price paid per share (USX)

Volume weighted average price paid per share (USX)

Trading venue

24 February 2020

103,000

56.17

55.5

55.867741

New York Stock Exchange ("NYSE")

25 February 2020

123,000

55.76

54.09

54.912993

NYSE

26 February 2020

123,000

54.87

54.05

54.428537

NYSE

27 February 2020

120,000

54.65

53.33

53.977516

NYSE

28 February 2020

120,000

51.97

50.23

51.015713

NYSE

 

Transaction details

 

The table below contains detailed information of the individual USX trades made by Credit Suisse Securities (USA) LLC as part of the Buyback Programme.

 

Schedule of purchases

 

Shares purchased:

Coca-Cola European Partners plc

(ISIN: GB00BDCPN049)

Dates of purchases:

24, 25, 26, 27 and 28 February 2020

Investment firm:

Credit Suisse Securities (USA) LLC

 

Individual transactions

 

A full breakdown of the individual transactions can be viewed at:

https://www.cocacolaep.com/assets/Governance_docs/Buyback-Announcements/0afa68bc8a/200302-Weekly-Buyback-Programme_trade-details.pdf

 

COCA-COLA EUROPEAN PARTNERS PLC

Paul van Reesch

Deputy Company Secretary

+44 (0) 1895 231 313

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSZLLFBBXLXBBE
Date   Source Headline
17th Mar 202311:55 amRNSAnnual Financial Report
14th Mar 20239:45 amRNSDirector/PDMR Shareholding
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20233:50 pmRNSDirector/PDMR Shareholding
1st Mar 20233:20 pmRNSTotal Voting Rights
23rd Feb 202310:30 amRNSDirector/PDMR Shareholding
16th Feb 20237:00 amRNSPreliminary Unaudited Results Q4 & FY 2022
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202310:00 amRNSDirectorate Change
1st Feb 20233:30 pmRNSTotal Voting Rights
23rd Jan 20234:30 pmRNSDirector/PDMR Shareholding
16th Jan 20232:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20232:40 pmRNSTotal Voting Rights
21st Dec 20223:45 pmRNSDirector/PDMR Shareholding
1st Dec 20223:15 pmRNSTotal Voting Rights
23rd Nov 20228:00 amRNSDirector/PDMR Shareholding
15th Nov 20225:30 pmRNSDirector/PDMR Shareholding
4th Nov 20225:20 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNSQ3, Investor Event & Interim Dividend Declaration
1st Nov 20223:45 pmRNSTotal Voting Rights
21st Oct 20223:00 pmRNSDirector/PDMR Shareholding
14th Oct 20222:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
22nd Sep 20223:00 pmRNSDirector/PDMR Shareholding
20th Sep 202210:00 amRNSBlock listing Interim Review
16th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20224:45 pmRNSDirector/PDMR Shareholding
1st Sep 20223:00 pmRNSTotal Voting Rights
22nd Aug 20224:00 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSResults for the six months ended 1 July 2022
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
1st Aug 20223:45 pmRNSTotal Voting Rights
20th Jul 20224:30 pmRNSDirector/PDMR Shareholding
14th Jul 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:30 pmRNSDirector/PDMR Shareholding
9th Jun 202212:00 pmRNSDirector/PDMR Shareholding
1st Jun 20223:10 pmRNSTotal Voting Rights
27th May 20223:30 pmRNSResult of AGM
24th May 20223:30 pmRNSDirector/PDMR Shareholding
16th May 202212:00 pmRNSLetter to Shareholders
3rd May 20222:40 pmRNSTotal Voting Rights
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSQ1 2022 Trading Update
21st Apr 20225:20 pmRNSDirector/PDMR Shareholding
14th Apr 20229:00 amRNSNotice of AGM
23rd Mar 20221:50 pmRNSDirector/PDMR Shareholding
18th Mar 20222:15 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.